Hallervorden-Spatz syndrome: infantile neuroaxonal dystrophy' complex: case report
Bresolin, A. U; Pascuzzi, L; Melaragno Filho, Roberto; Fontana, Maria Helena; Pecora, R; Dias, José Candido de Souza.
Arq. neuropsiquiatr
; 46(1): 69-72, mar. 1988. ilus
Artículo en Inglés | LILACS | ID: lil-51842
Documentos relacionados
Pantothenate Kinase Associated Neurodegeneration-A Rare Case Report.
Olfactory status in neurodegeneration with brain iron accumulation disorders.
A surprising presentation of atypical pantothenate kinase-associated neurodegeneration disorder: metamorphopsia.
Atypical pantothenate kinase-associated neurodegeneration with PANK2 mutations : clinical description and a review of the literature.
[«A most strange instance of illness in several siblings¼--first description of a rare neurological disease in 1830?].
Incidence of PKAN determined by bioinformatic and population-based analysis of ~140,000 humans.
First successful trial of preimplantation genetic diagnosis for pantothenate kinase-associated neurodegeneration.
Renaming of Hallervorden-Spatz disease: the second man behind the name of the disease.
<i>PANK2</i> p.A170fsï¼a novel pathogenetic mutation, compound with <i>PANK2</i> p.R440P, causing pantothenate kinase Associated neurodegeneration in a Chinese family.
Rational Design of Novel Therapies for Pantothenate Kinase-Associated Neurodegeneration.